emerging treatment options for mcrc patients in the late-line setting
Published 8 years ago • 198 plays • Length 18:55Download video MP4
Download video MP3
Similar videos
-
28:29
metastatic colorectal cancer: optimizing dosing strategy for late-line therapies
-
35:27
expert perspectives: optimizing late-line therapy for patients with metastatic colorectal cancer
-
15:12
initial management of metastatic crc in 2019
-
15:47
management of adverse events associated with third-line mcrc treatments
-
11:00
therapeutic sequencing & emerging therapies for mcrc
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
8:36
debate: is there an optimal sequence for first-line therapy in mcrc? - yes
-
1:32
the role of autosct in waldenström's macroglobulinemia and eligibility criteria
-
7:32
treatment options in refractory mcrc
-
12:16
selecting the optimal first-line treatment in advanced colorectal cancer
-
7:37
debate: msi high colon cancer - upfront chemotherapy
-
3:04
treatment goals in refractory mcrc
-
8:04
first- and second-line treatment for mcrc in specific populations
-
7:35
treatment options for third-line therapy in mcrc
-
13:18
debate 1: first-line treatment of metastatic colorectal cancer - calgb 80405
-
7:43
therapy in the salvage setting of mcrc
-
25:06
colorectal cancer: sequencing and therapeutic approaches in first- and next-line treatment
-
22:46
mutational testing and the treatment of colorectal cancer
-
10:30
debate 1: first-line treatment of metastatic colorectal cancer - fire-3